In this article, ORIGIN researcher Dr Orla Houlihan describes the potential role for in vivo dosimetry in the reduction of uncertainties in pelvic brachytherapy, the pertinent factors for consideration in clinical practice, and the future potential for in vivo dosimetry in the personalisation of brachytherapy.
Add a Comment
You must be logged in to post a comment